Company intelligence / Profile preview

NXP Semiconductors

Eindhoven, Netherlandsnxp.com ↗

Ownership: Private
Employees: ~33100
Development stage: Commercial

Overview

NXP Semiconductors does not develop therapeutics or diagnostics but provides semiconductor technologies that enable secure connectivity in healthcare devices. It has launched a therapy adherence platform using NFC-enabled sensors for medication tracking and has achieved IEC 81001‑5‑1 certification for cybersecurity in connected healthcare applications.

Industry: Chemicals & Materials

Partnerships

Collaborates with pharmaceutical companies, medical packaging firms, application developers on digital health solutions such as the therapy adherence platform

Beyond the preview

Go deeper on NXP Semiconductors.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NXP Semiconductors.

Explore the full profile